Linda Mann1, Paul Salmon2, Deep Chandh Raja3. 1. YourDoctors, Sydney. 2. Sydney. 3. Cardiac Electrophysiology Unit, Department of Cardiology, Canberra Hospital and Health Services, Australian National University.
Letter to the editor 1, authored by Linda MannThe recent article about atrial fibrillation1 states that the QT interval should be closely monitored, and sotalol is relatively contraindicated in patients with chronic renal impairment. How do we monitor QT interval in atrial fibrillation when it is not measurable?Linda Mann, General practitionerYourDoctors, SydneyLetter to the editor 2, authored by Paul SalmonGreat article on atrial fibrillation1a, but why is there no mention of cryoablation when radiofrequency ablation was mentioned?Paul Salmon, RadiologistSydneyDeep Chandh Raja, one of the authors of the article, comments:In response to Linda Mann’s query, we suggest measuring the QT interval in atrial fibrillation as an average over five ventricular beats. This has been shown to correspond very closely to the QT interval of the same patients in sinus rhythm, when corrected for heart rate.1b A heart rate correction formula (e.g. Bazett’s) should be used, however there is no robust evidence to show superiority of one particular formula over the other.1bWith regards to the query from Paul Salmon about catheter ablation, there are different sources of energy for catheter ablation – radiofrequency energy, cryotherapy and pulsed field ablation.2b Radiofrequency energy continues to remain the widely practised mode of catheter ablation, although radiofrequency energy and cryotherapy have similar efficacy rates. Pulsed field ablation or electroporation has recently shown promising results in the first-in-human trials.2b
Authors: James Tooley; David Ouyang; David Hadley; Mintu Turakhia; Paul Wang; Euan Ashley; Victor Froelicher; Marco Perez Journal: Am J Cardiol Date: 2019-03-13 Impact factor: 2.778
Authors: Vivek Y Reddy; Petr Neuzil; Jacob S Koruth; Jan Petru; Moritoshi Funosako; Hubert Cochet; Lucie Sediva; Milan Chovanec; Srinivas R Dukkipati; Pierre Jais Journal: J Am Coll Cardiol Date: 2019-05-11 Impact factor: 24.094